The rumors are officially real. Following months of speculation surrounding a multi-billion ringgit listing, Big Caring Group Bhd has taken a massive leap forward by officially filing its draft initial public offering (IPO) prospectus with the Securities Commission Malaysia.
Thank you for reading this post, don't forget to subscribe!The company is seeking to raise a staggering $750 million (approx. RM3.15 billion to RM3.5 billion), matching early expectations. This deal is shaping up to be one of Malaysia’s largest capital market listings in recent memory, targeting a total valuation that analysts predict could touch RM20 billion ($4.8 billion).
The IPO Breakdown
According to regulatory filings, Big Caring is looking to float an equity stake of up to 25.5% on the Main Market of Bursa Malaysia:
- Total Offering: Up to 1,882,368,000 ordinary shares.
- The Split: A combination of an offer for sale (up to 1.29 billion existing shares, allowing early backers to cash out) and a public issue of roughly 590.5 million brand-new shares.
- Where the Money is Going: Fresh capital from the new shares will primarily fund a brand-new distribution center and pay down existing bank debt.
- Target Market: The vast majority of the shares are earmarked for institutional and selected investors, with the remaining fraction open to retail investors.
The Rise of a Pharma Titan
Big Caring Group is a powerhouse born out of a massive 2023 consolidation wave:
The Merger: The group was formed when BIG Pharmacy Healthcare (founded in 2016 by pharmacists Lee Meng Chuan and Lim Sin Yin) acquired Caring Pharmacy Group from 7-Eleven Malaysia Holdings for RM900 million.
The combined entity is heavily backed by Creador, a prominent Kuala Lumpur-based private equity firm holding a 35% stake in the mega-chain.
Today, Big Caring is unchallenged as Malaysia’s largest pharmaceutical retailer, boasting a footprint of 626 stores nationwide—with active plans to roll out another 50 outlets over the next three to five years. The group is aiming to position itself as a fully integrated healthcare ecosystem spanning digital health services, wholesale distribution, and product manufacturing.
The Heavyweight Advisory Team
To successfully pull off a deal of this magnitude, the group has lined up a syndicate of top-tier investment banks:
- Joint Principal Advisers & Coordinators: Maybank Investment Bank, RHB Investment Bank, and AmInvestment Bank.
- International Reach: UBS has been tapped as a joint global coordinator and bookrunner to capture foreign institutional demand.
A formal pricing timeline and retail launch date will follow once the Securities Commission completes its review of the draft prospectus.
